Work

A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally administered VT-1161 in the treatment of recurrent vulvovaginal candidiasis

Year: 2018

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: American Journal of Obstetrics and Gynecology

DOI: 10.1016/j.ajog.2018.03.001

Authors: Stephen R. Brand, Thorsten P. Degenhardt, Karen Person, Jack D. Sobel, Paul Nyirjesy, Robert J. Schotzinger, Amir Tavakkol

Institutions: Viamet Pharmaceuticals (United States), Wayne State University, Drexel University

Language: English

Topic: Antifungal resistance and susceptibility

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2790841582

FWCI: 7.303

Cites: 23

Cited by: 78

Related to: 10